Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients

Name: Work Video:
Duration: 3 min 30 s
Éric Dailly; Clotilde Allavena; Régis Bouquié; Guillaume Deslandes; François Raffi; Pascale Jolliet
{'id': 'https://openalex.org/W2029756679', 'doi': 'https://doi.org/10.1089/aid.2012.0188', 'title': 'Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients', 'display_name': 'Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients', 'publication_year': 2012, 'publication_date': '2012-11-14', 'ids': {'openalex': 'https://openalex.org/W2029756679', 'doi': 'https://doi.org/10.1089/aid.2012.0188', 'mag': '2029756679', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/23148588'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1089/aid.2012.0188', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S161282271', 'display_name': 'AIDS Research and Human Retroviruses', 'issn_l': '0889-2229', 'issn': ['0889-2229', '1931-8405'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320443', 'host_organization_name': 'Mary Ann Liebert, Inc.', 'host_organization_lineage': ['https://openalex.org/P4310320443'], 'host_organization_lineage_names': ['Mary Ann Liebert, Inc.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5081490269', 'display_name': 'Éric Dailly', 'orcid': 'https://orcid.org/0000-0002-5400-335X'}, 'institutions': [{'id': 'https://openalex.org/I4210128055', 'display_name': "Centre d'Investigation Clinique de Nantes", 'ror': 'https://ror.org/02ct41845', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I154526488', 'https://openalex.org/I3019204325', 'https://openalex.org/I4210105774', 'https://openalex.org/I4210128055']}, {'id': 'https://openalex.org/I3019204325', 'display_name': 'Centre Hospitalier Universitaire de Nantes', 'ror': 'https://ror.org/05c1qsg97', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019204325']}, {'id': 'https://openalex.org/I97188460', 'display_name': 'Nantes Université', 'ror': 'https://ror.org/03gnr7b55', 'country_code': 'FR', 'type': 'education', 'lineage': ['https://openalex.org/I97188460']}], 'countries': ['FR'], 'is_corresponding': True, 'raw_author_name': 'Eric Dailly', 'raw_affiliation_strings': ['Clinical Pharmacology Department, CHU de Nantes, Nantes, France.', 'EA 4275 Biostatistique, Pharmacoépidémiologie et Mesures Subjectives en Santé, Faculté de Médecine–Pharmacie, Université de Nantes, Nantes, France.'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology Department, CHU de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I4210128055', 'https://openalex.org/I3019204325']}, {'raw_affiliation_string': 'EA 4275 Biostatistique, Pharmacoépidémiologie et Mesures Subjectives en Santé, Faculté de Médecine–Pharmacie, Université de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I97188460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018167374', 'display_name': 'Clotilde Allavena', 'orcid': 'https://orcid.org/0000-0003-1010-1270'}, 'institutions': [{'id': 'https://openalex.org/I3019204325', 'display_name': 'Centre Hospitalier Universitaire de Nantes', 'ror': 'https://ror.org/05c1qsg97', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019204325']}, {'id': 'https://openalex.org/I97188460', 'display_name': 'Nantes Université', 'ror': 'https://ror.org/03gnr7b55', 'country_code': 'FR', 'type': 'education', 'lineage': ['https://openalex.org/I97188460']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Clotilde Allavena', 'raw_affiliation_strings': ['EA 4271 Immunovirologie et Polymorphisme Génétique, Faculté de Médecine-Pharmacie, Université de Nantes, Nantes, France.', 'Infectious Diseases Department, CHU de Nantes, Nantes, France.'], 'affiliations': [{'raw_affiliation_string': 'Infectious Diseases Department, CHU de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I3019204325']}, {'raw_affiliation_string': 'EA 4271 Immunovirologie et Polymorphisme Génétique, Faculté de Médecine-Pharmacie, Université de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I97188460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015915568', 'display_name': 'Régis Bouquié', 'orcid': 'https://orcid.org/0000-0003-3818-4389'}, 'institutions': [{'id': 'https://openalex.org/I4210128055', 'display_name': "Centre d'Investigation Clinique de Nantes", 'ror': 'https://ror.org/02ct41845', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I154526488', 'https://openalex.org/I3019204325', 'https://openalex.org/I4210105774', 'https://openalex.org/I4210128055']}, {'id': 'https://openalex.org/I3019204325', 'display_name': 'Centre Hospitalier Universitaire de Nantes', 'ror': 'https://ror.org/05c1qsg97', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019204325']}, {'id': 'https://openalex.org/I97188460', 'display_name': 'Nantes Université', 'ror': 'https://ror.org/03gnr7b55', 'country_code': 'FR', 'type': 'education', 'lineage': ['https://openalex.org/I97188460']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Regis Bouquié', 'raw_affiliation_strings': ['Clinical Pharmacology Department, CHU de Nantes, Nantes, France.', 'EA 4275 Biostatistique, Pharmacoépidémiologie et Mesures Subjectives en Santé, Faculté de Médecine–Pharmacie, Université de Nantes, Nantes, France.'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology Department, CHU de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I4210128055', 'https://openalex.org/I3019204325']}, {'raw_affiliation_string': 'EA 4275 Biostatistique, Pharmacoépidémiologie et Mesures Subjectives en Santé, Faculté de Médecine–Pharmacie, Université de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I97188460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080096821', 'display_name': 'Guillaume Deslandes', 'orcid': 'https://orcid.org/0000-0003-4587-7634'}, 'institutions': [{'id': 'https://openalex.org/I4210128055', 'display_name': "Centre d'Investigation Clinique de Nantes", 'ror': 'https://ror.org/02ct41845', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I154526488', 'https://openalex.org/I3019204325', 'https://openalex.org/I4210105774', 'https://openalex.org/I4210128055']}, {'id': 'https://openalex.org/I3019204325', 'display_name': 'Centre Hospitalier Universitaire de Nantes', 'ror': 'https://ror.org/05c1qsg97', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019204325']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Guillaume Deslandes', 'raw_affiliation_strings': ['Clinical Pharmacology Department, CHU de Nantes, Nantes, France.'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology Department, CHU de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I4210128055', 'https://openalex.org/I3019204325']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110215337', 'display_name': 'François Raffi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I97188460', 'display_name': 'Nantes Université', 'ror': 'https://ror.org/03gnr7b55', 'country_code': 'FR', 'type': 'education', 'lineage': ['https://openalex.org/I97188460']}, {'id': 'https://openalex.org/I3019204325', 'display_name': 'Centre Hospitalier Universitaire de Nantes', 'ror': 'https://ror.org/05c1qsg97', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019204325']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'François Raffi', 'raw_affiliation_strings': ['EA 4271 Immunovirologie et Polymorphisme Génétique, Faculté de Médecine-Pharmacie, Université de Nantes, Nantes, France.', 'Infectious Diseases Department, CHU de Nantes, Nantes, France.'], 'affiliations': [{'raw_affiliation_string': 'EA 4271 Immunovirologie et Polymorphisme Génétique, Faculté de Médecine-Pharmacie, Université de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I97188460']}, {'raw_affiliation_string': 'Infectious Diseases Department, CHU de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I3019204325']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5042468344', 'display_name': 'Pascale Jolliet', 'orcid': 'https://orcid.org/0000-0003-0191-9249'}, 'institutions': [{'id': 'https://openalex.org/I3019204325', 'display_name': 'Centre Hospitalier Universitaire de Nantes', 'ror': 'https://ror.org/05c1qsg97', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019204325']}, {'id': 'https://openalex.org/I4210128055', 'display_name': "Centre d'Investigation Clinique de Nantes", 'ror': 'https://ror.org/02ct41845', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I154526488', 'https://openalex.org/I3019204325', 'https://openalex.org/I4210105774', 'https://openalex.org/I4210128055']}, {'id': 'https://openalex.org/I97188460', 'display_name': 'Nantes Université', 'ror': 'https://ror.org/03gnr7b55', 'country_code': 'FR', 'type': 'education', 'lineage': ['https://openalex.org/I97188460']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Pascale Jolliet', 'raw_affiliation_strings': ['Clinical Pharmacology Department, CHU de Nantes, Nantes, France.', 'EA 4275 Biostatistique, Pharmacoépidémiologie et Mesures Subjectives en Santé, Faculté de Médecine–Pharmacie, Université de Nantes, Nantes, France.'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology Department, CHU de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I3019204325', 'https://openalex.org/I4210128055']}, {'raw_affiliation_string': 'EA 4275 Biostatistique, Pharmacoépidémiologie et Mesures Subjectives en Santé, Faculté de Médecine–Pharmacie, Université de Nantes, Nantes, France.', 'institution_ids': ['https://openalex.org/I97188460']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': ['https://openalex.org/A5081490269'], 'corresponding_institution_ids': ['https://openalex.org/I4210128055', 'https://openalex.org/I3019204325', 'https://openalex.org/I97188460'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.331, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.531453, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 75, 'max': 78}, 'biblio': {'volume': '29', 'issue': '1', 'first_page': '42', 'last_page': '46'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'HIV Research and Treatment', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11655', 'display_name': 'HIV-related health complications and treatments', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/2711', 'display_name': 'Emergency Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/etravirine', 'display_name': 'Etravirine', 'score': 0.9417746}, {'id': 'https://openalex.org/keywords/darunavir', 'display_name': 'Darunavir', 'score': 0.9125242}, {'id': 'https://openalex.org/keywords/raltegravir', 'display_name': 'Raltegravir', 'score': 0.8835597}, {'id': 'https://openalex.org/keywords/nevirapine', 'display_name': 'Nevirapine', 'score': 0.8498083}, {'id': 'https://openalex.org/keywords/efavirenz', 'display_name': 'Efavirenz', 'score': 0.8304376}, {'id': 'https://openalex.org/keywords/ritonavir', 'display_name': 'Ritonavir', 'score': 0.73580873}, {'id': 'https://openalex.org/keywords/population-pharmacokinetics', 'display_name': 'Population Pharmacokinetics', 'score': 0.45913842}], 'concepts': [{'id': 'https://openalex.org/C2780345285', 'wikidata': 'https://www.wikidata.org/wiki/Q414762', 'display_name': 'Etravirine', 'level': 5, 'score': 0.9417746}, {'id': 'https://openalex.org/C2779182219', 'wikidata': 'https://www.wikidata.org/wiki/Q3765251', 'display_name': 'Darunavir', 'level': 5, 'score': 0.9125242}, {'id': 'https://openalex.org/C2780404665', 'wikidata': 'https://www.wikidata.org/wiki/Q421552', 'display_name': 'Raltegravir', 'level': 5, 'score': 0.8835597}, {'id': 'https://openalex.org/C2779130552', 'wikidata': 'https://www.wikidata.org/wiki/Q263713', 'display_name': 'Nevirapine', 'level': 5, 'score': 0.8498083}, {'id': 'https://openalex.org/C2781432083', 'wikidata': 'https://www.wikidata.org/wiki/Q422645', 'display_name': 'Efavirenz', 'level': 5, 'score': 0.8304376}, {'id': 'https://openalex.org/C2779298103', 'wikidata': 'https://www.wikidata.org/wiki/Q422618', 'display_name': 'Ritonavir', 'level': 5, 'score': 0.73580873}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.64806145}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.5801646}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5633031}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.50759375}, {'id': 'https://openalex.org/C3020755252', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Population pharmacokinetics', 'level': 3, 'score': 0.45913842}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.4278255}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.38900375}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.21825272}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.14175078}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D017320', 'descriptor_name': 'HIV Protease Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019829', 'descriptor_name': 'Nevirapine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011760', 'descriptor_name': 'Pyrrolidinones', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000480', 'descriptor_name': 'Alkynes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D023241', 'descriptor_name': 'Antiretroviral Therapy, Highly Active', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023241', 'descriptor_name': 'Antiretroviral Therapy, Highly Active', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048588', 'descriptor_name': 'Benzoxazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003521', 'descriptor_name': 'Cyclopropanes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069454', 'descriptor_name': 'Darunavir', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004357', 'descriptor_name': 'Drug Synergism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017320', 'descriptor_name': 'HIV Protease Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D017320', 'descriptor_name': 'HIV Protease Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D017320', 'descriptor_name': 'HIV Protease Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019829', 'descriptor_name': 'Nevirapine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019829', 'descriptor_name': 'Nevirapine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011760', 'descriptor_name': 'Pyrrolidinones', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011760', 'descriptor_name': 'Pyrrolidinones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068898', 'descriptor_name': 'Raltegravir Potassium', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D013449', 'descriptor_name': 'Sulfonamides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1089/aid.2012.0188', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S161282271', 'display_name': 'AIDS Research and Human Retroviruses', 'issn_l': '0889-2229', 'issn': ['0889-2229', '1931-8405'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320443', 'host_organization_name': 'Mary Ann Liebert, Inc.', 'host_organization_lineage': ['https://openalex.org/P4310320443'], 'host_organization_lineage_names': ['Mary Ann Liebert, Inc.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/23148588', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.77}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 21, 'referenced_works': ['https://openalex.org/W179970603', 'https://openalex.org/W1965922975', 'https://openalex.org/W1987092148', 'https://openalex.org/W1990380448', 'https://openalex.org/W1998551235', 'https://openalex.org/W1998690882', 'https://openalex.org/W2008354232', 'https://openalex.org/W2028787913', 'https://openalex.org/W2033823934', 'https://openalex.org/W2055762134', 'https://openalex.org/W2072593795', 'https://openalex.org/W2082406198', 'https://openalex.org/W2090905584', 'https://openalex.org/W2139772076', 'https://openalex.org/W2140541224', 'https://openalex.org/W2152934710', 'https://openalex.org/W2160872860', 'https://openalex.org/W2161384285', 'https://openalex.org/W2165447838', 'https://openalex.org/W2169012191', 'https://openalex.org/W2329526205'], 'related_works': ['https://openalex.org/W2598090732', 'https://openalex.org/W2169012191', 'https://openalex.org/W2160587450', 'https://openalex.org/W2160564051', 'https://openalex.org/W2099470553', 'https://openalex.org/W2068921955', 'https://openalex.org/W2027642737', 'https://openalex.org/W2013830391', 'https://openalex.org/W1995527793', 'https://openalex.org/W1569413592'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1, 22], 'influence': [2, 133], 'of': [3, 13, 26, 123, 137, 144, 165], 'efavirenz,': [4, 150], 'etravirine,': [5], 'raltegravir,': [6], 'and': [7, 71, 75, 92, 110, 126, 147, 158], 'nevirapine': [8, 90, 148], 'administration': [9], 'on': [10, 134], 'the': [11, 114, 121, 135, 142, 162], 'pharmacokinetics': [12, 20, 136], 'ritonavir-boosted': [14, 124, 145], 'darunavir': [15, 32, 43, 50, 57, 64, 72, 85, 125, 138, 146, 156], 'was': [16, 24, 95, 105], 'investigated': [17], 'using': [18], 'population': [19, 23], 'analysis.': [21], 'composed': [25], '142': [27], 'patients': [28, 40, 47, 54, 61, 68, 78], 'infected': [29], 'with': [30, 89, 113], 'HIV:': [31], 'plus': [33, 44, 51, 58, 65, 73], 'nucleoside/nucleotide': [34], 'reverse': [35], 'transcriptase': [36], 'inhibitors': [37], '(NRTI),': [38], '54': [39], '(group': [41, 48, 55, 62, 69, 79], 'A);': [42], 'efavirenz±NRTI,': [45], '4': [46], 'B);': [49], 'etravirine±NRTI,': [52, 76], '5': [53], 'C);': [56], 'nevirapine±NRTI,': [59], '21': [60], 'D);': [63], 'raltegravir±NRTI,': [66], '38': [67], 'E);': [70], 'raltegravir': [74, 129], '20': [77], 'F).': [80], 'A': [81, 97], 'significant': [82, 98, 132], 'increase': [83, 154], 'in': [84, 87, 101, 107, 139, 155, 161], 'clearance': [86, 157], 'combination': [88, 122, 143], '(+66%)': [91], 'efavirenz': [93], '(+235%)': [94], 'observed.': [96], 'decrease': [99, 160], '(p<0.05)': [100], 'trough': [102], 'plasma': [103, 163], 'concentration': [104, 164], 'observed': [106], 'groups': [108], 'B': [109], 'D': [111], 'compared': [112], 'other': [115], 'groups.': [116], 'Our': [117], 'study': [118], 'indicates': [119], 'that': [120], 'etravirine': [127], 'or': [128, 149], 'has': [130], 'no': [131], 'contrast': [140], 'to': [141], 'which': [151], 'involves': [152], 'an': [153], 'a': [159], 'darunavir.': [166]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2029756679', 'counts_by_year': [{'year': 2016, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}], 'updated_date': '2024-12-13T10:30:31.693030', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
